User profiles for Hikmat Abdel-Razeq
 | Hikmat Abdel-Razeq,MD.Professor of Medicine Verified email at khcc.jo Cited by 1877 |
Breast cancer care in Jordan
H Abdel-Razeq, A Mansour, D Jaddan - JCO global oncology, 2020 - ascopubs.org
Breast cancer is the most common malignancy in Jordan and the third leading cause of
cancer death after lung and colorectal cancers. Although the incidence of breast cancer in …
cancer death after lung and colorectal cancers. Although the incidence of breast cancer in …
[HTML][HTML] Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia
H Abdel-Razeq, H Hashem - Critical reviews in oncology/hematology, 2020 - Elsevier
Cancer and chemotherapy-induced anemia (CIA) is commonly encountered among patients
undergoing active chemotherapy with or without radiation therapy. Its pathogenesis is …
undergoing active chemotherapy with or without radiation therapy. Its pathogenesis is …
[HTML][HTML] Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients
H Abdel-Razeq, S Iweir, R Abdel-Razeq… - Scientific Reports, 2021 - nature.com
In developing countries, breast cancer is diagnosed at a much younger age. In this study we
investigate the dichotomies between older and young breast cancer patients in our region. …
investigate the dichotomies between older and young breast cancer patients in our region. …
[HTML][HTML] Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
H Abdel-Razeq, A Al-Omari, F Zahran, B Arun - BMC cancer, 2018 - Springer
Background Breast cancer is the most common malignancy and the leading cause of cancer-related
deaths among Jordanian women. With a median age of 50 years at diagnosis, a …
deaths among Jordanian women. With a median age of 50 years at diagnosis, a …
A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS–Cancer‐Associated thrombosis study
Background The stratification of outpatients on chemotherapy for breast, colorectal, lung, and
ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical need. …
ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical need. …
[HTML][HTML] Cancer care in Jordan
H Abdel-Razeq, F Attiga, A Mansour - Hematology/oncology and stem cell …, 2015 - Elsevier
Cancer is the second leading cause of death in Jordan after cardiovascular diseases. Due
to increase in life expectancy and prolonged exposure to risk factors, cancer mortality and …
to increase in life expectancy and prolonged exposure to risk factors, cancer mortality and …
[HTML][HTML] MR imaging features of intracranial primary CNS lymphoma in immune competent patients
We aimed to characterize specific MRI findings seen in immune competent patients with
intracranial primary CNS lymphoma (PCNSL) and to determine their value in the management …
intracranial primary CNS lymphoma (PCNSL) and to determine their value in the management …
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome–a comprehensive cancer center experience
HN Abdel-Razeq, AH Mansour… - Vascular health and risk …, 2011 - Taylor & Francis
Background and objectives: Cancer patients undergo routine imaging studies much more
than others. The widespread use of the recently introduced multi-detector CT scanners has …
than others. The widespread use of the recently introduced multi-detector CT scanners has …
[HTML][HTML] The COVID-19 pandemic and the need for an integrated and equitable approach: an international expert consensus paper
Background One year after the declaration of the coronavirus disease 2019 (COVID-19)
pandemic by the World Health Organization (WHO) and despite the implementation of …
pandemic by the World Health Organization (WHO) and despite the implementation of …
Current neoadjuvant treatment options for HER2-positive breast cancer
H Abdel-Razeq, L Marei - Biologics: Targets and Therapy, 2011 - Taylor & Francis
Approximately one quarter of patients with breast cancer demonstrate amplification of the
human epidermal receptor type 2 (HER2) gene, the expression of which is associated with a …
human epidermal receptor type 2 (HER2) gene, the expression of which is associated with a …
